Factors affecting in-hospital mortality among pediatric patients with myocarditis treated with mechanical circulatory

Susumu Urata1, Nobuaki Michihata2, Ryo Inuzuka3

  • 1Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan; Division of Cardiology, National Center for Child and Development, Tokyo, Japan.

Journal of Cardiology
|March 30, 2023
PubMed

Insights

Mortality remains high for pediatric myocarditis patients on mechanical circulatory support (MCS). Younger children and those needing cardiopulmonary resuscitation (CPR) face significantly increased in-hospital death risks.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Cardiovascular Research

Background:

  • Pediatric myocarditis often necessitates mechanical circulatory support (MCS) for circulatory failure.
  • Despite advancements, in-hospital mortality rates for pediatric patients with myocarditis undergoing MCS remain a significant concern.
  • Identifying mortality predictors is crucial for improving outcomes in this vulnerable population.

Purpose of the Study:

  • To identify factors associated with in-hospital mortality in pediatric patients with myocarditis treated with MCS.
  • To inform clinical strategies aimed at reducing mortality in this patient group.

Main Methods:

  • Retrospective cohort study utilizing Japan's national inpatient database (Diagnosis Procedure Combination).
  • Inclusion criteria: Patients aged <16 years admitted for myocarditis between July 2010 and March 2018.
  • Analysis focused on 98 eligible patients treated with MCS, excluding those deceased within 24 hours of admission.

Main Results:

  • Overall in-hospital mortality was 22% among the 98 eligible pediatric patients.
  • In-hospital mortality was significantly higher in patients younger than 2 years (OR, 6.57; 95% CI, 1.89-22.87).
  • Patients who received cardiopulmonary resuscitation (CPR) also had significantly higher in-hospital mortality (OR, 4.70; 95% CI, 1.51-14.63).

Conclusions:

  • In-hospital mortality for pediatric myocarditis patients on MCS is high.
  • Younger age (<2 years) and the need for CPR are significant risk factors for mortality.
  • These findings highlight critical subgroups requiring intensified monitoring and potentially tailored interventions.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
10
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
14
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
724
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K